Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PEG-m-THPC-mediated photodynamic effects on normal rat tissues.

R Hornung1, M K Fehr, H Walt

  • 1Beckman Laser Institute and Medical Clinic, University of California, Irvine, USA. renehornung@clinch.ch

Photochemistry and Photobiology
|December 7, 2000
PubMed
Summary

Photodynamic therapy (PDT) using PEG-m-THPC shows promise for cancer treatment. Studies in rats indicate it

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Vibration as a risk of mastitis during milking].

Schweizer Archiv fur Tierheilkunde·2024
Same author

The spatial distribution of perseverations in neglect patients during a nonverbal fluency task depends on the integrity of the right putamen.

Neuropsychologia·2018
Same author

Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in female cancer patients.

Current oncology (Toronto, Ont.)·2017
Same author

Archives of gynecology and obstetrics·2016
Same author

Archives of gynecology and obstetrics·2016
Same author

Archives of gynecology and obstetrics·2016

Area of Science:

  • Oncology
  • Photodynamic Therapy
  • Biomaterials

Background:

  • Photodynamic therapy (PDT) utilizes light-activated photosensitizers for cancer treatment.
  • PEG-m-THPC is the first pegylated photosensitizer, designed for enhanced accumulation in cancer cells.
  • Assessing PDT's safety in normal tissues is crucial for clinical application.

Purpose of the Study:

  • To evaluate the photodynamic threshold for damage in normal rat tissues using PEG-m-THPC.
  • To determine the sequelae and regenerative capacity of tissues following PDT.
  • To establish safe dosage and light parameters for PEG-m-THPC in non-tumor tissues.

Main Methods:

  • Fischer rats (n=35) received varying doses of PEG-m-THPC (3, 9, 30 mg/kg).
  • Tissues (colon, vagina, perineum) were irradiated with 652 nm laser light at different optical doses (50, 150, 450 J/cm).

Related Experiment Videos

  • Histological assessment of tissue damage and healing was performed at 3 and 8 weeks post-PDT.

    • Main Results:

    • No dark toxicity was observed.
    • High-dose PEG-m-THPC (30 mg/kg) caused severe necrosis, while lower doses (3-9 mg/kg) with limited light exposure resulted in moderate or no damage.
    • Tissues subjected to severe PDT damage demonstrated good regenerative potential.
    • No significant increase in pelvic temperature was noted during PDT.

    Conclusions:

    • PEG-m-THPC demonstrates safety and promising properties as a photosensitizer for tumor treatment.
    • PDT on colon mucosa appears safe below 9 mg/kg PEG-m-THPC and 150 J/cm.
    • Other normal tissues tolerate 9 mg/kg PEG-m-THPC activated with <450 J/cm with minimal side effects, suggesting a favorable safety profile.